Considering that some of the strongest associations of the PTPN22 1858C/T are with autoimmune diseases characterized by the production of circulating autoantibodies, dysregulation of B-cell clonal deletion and receptor editing is likely to contribute to PTPN22-associated autoimmune diseases [19]. Here, PTPN22 is linked to autoimmune disease.